187 related articles for article (PubMed ID: 15585550)
21. Beneficial effects of high daily dose bromocriptine treatment in Cushing's disease.
Mercado-Asis LB; Yasuda K; Murayama M; Mune T; Morita H; Miura K
Endocrinol Jpn; 1992 Aug; 39(4):385-95. PubMed ID: 1332855
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of plasma cortisol and ACTH responses to dexamethasone in healthy subjects.
Sherman BM; Schlechte JA; Pfohl BM
Horm Res; 1984; 20(3):157-65. PubMed ID: 6092256
[TBL] [Abstract][Full Text] [Related]
23. Plasma cortisol response to ACTH does not accurately indicate the state of hypothalamic-pituitary-adrenal axis.
Reschini E; Catania A; Giustina G
J Endocrinol Invest; 1982; 5(4):259-61. PubMed ID: 6294171
[TBL] [Abstract][Full Text] [Related]
24. A revised interpretation of postdexamethasone ACTH and cortisol findings in unipolar depressed females.
Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Blockx P
Psychiatry Res; 1990 Nov; 34(2):107-26. PubMed ID: 1962860
[TBL] [Abstract][Full Text] [Related]
25. The effect of medroxyprogesterone acetate on the pituitary-adrenal axis.
Hellman L; Yoshida K; Zumoff B; Levin J; Kream J; Fukushima DK
J Clin Endocrinol Metab; 1976 May; 42(5):912-7. PubMed ID: 178684
[TBL] [Abstract][Full Text] [Related]
26. Cortisol receptor resistance: the variability of its clinical presentation and response to treatment.
Lamberts SW; Koper JW; Biemond P; den Holder FH; de Jong FH
J Clin Endocrinol Metab; 1992 Feb; 74(2):313-21. PubMed ID: 1309833
[TBL] [Abstract][Full Text] [Related]
27. Hypothalamic-pituitary-adrenocortical function during long-term low-dose dexamethasone therapy in hyperandrogenized women.
Boyers SP; Buster JE; Marshall JR
Am J Obstet Gynecol; 1982 Feb; 142(3):330-9. PubMed ID: 6278932
[TBL] [Abstract][Full Text] [Related]
28. [Effect of large doses of reserpine on the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing's disease].
Marova EI; Butrova SA; Kolesnikova GS
Probl Endokrinol (Mosk); 1978; 24(2):17-21. PubMed ID: 205862
[TBL] [Abstract][Full Text] [Related]
29. Sodium loading raises urinary cortisol in man.
Wambach G; Bleienheuft C; Bönner G
J Endocrinol Invest; 1986 Jun; 9(3):257-9. PubMed ID: 3020116
[TBL] [Abstract][Full Text] [Related]
30. Clinical Utility of Osilodrostat in Cushing's Disease: Review of Currently Available Literature.
Perosevic M; Tritos NA
Drug Des Devel Ther; 2023; 17():1303-1312. PubMed ID: 37143705
[TBL] [Abstract][Full Text] [Related]
31. Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma.
Beyer HS; Doe RP
J Clin Endocrinol Metab; 1986 Jun; 62(6):1317-21. PubMed ID: 3009524
[TBL] [Abstract][Full Text] [Related]
32. Evidence for extrapituitary mechanisms mediating the morning peak of plasma cortisol in man.
Fehm HL; Klein E; Holl R; Voigt KH
J Clin Endocrinol Metab; 1984 Mar; 58(3):410-4. PubMed ID: 6319450
[TBL] [Abstract][Full Text] [Related]
33. Imipramine effect on hypothalamic-pituitary-adrenal axis response to hypoglycemia.
Kathol RG; Jaeckle R; Wysham C; Sherman BM
Psychiatry Res; 1992 Jan; 41(1):45-52. PubMed ID: 1313983
[TBL] [Abstract][Full Text] [Related]
34. Recovery of hypothalamic-pituitary-adrenal function after long term suppression by aminoglutethimide and hydrocortisone.
Worgul TJ; Kendall J; Santen RJ
J Clin Endocrinol Metab; 1981 Oct; 53(4):879-82. PubMed ID: 6270177
[TBL] [Abstract][Full Text] [Related]
35. Adrenocorticotropin-cortisol axis abnormalities in hemodialysis patients.
McDonald WJ; Golper TA; Mass RD; Kendall JW; Porter GA; Girard DE; Fischer MD
J Clin Endocrinol Metab; 1979 Jan; 48(1):92-5. PubMed ID: 217891
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of adrenal cortisol secretion after intravenous high dose dexamethasone.
Graybeal ML; Fang VS; Landau RL
J Clin Endocrinol Metab; 1985 Oct; 61(4):607-11. PubMed ID: 2993341
[TBL] [Abstract][Full Text] [Related]
37. Cortisol suppression test in patients with elevated adrenocorticotropic hormone levels.
Koletsky RJ; Dluhy RG; Crantz FR; Williams GH
Ann Intern Med; 1982 Mar; 96(3):277-80. PubMed ID: 6277220
[TBL] [Abstract][Full Text] [Related]
38. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
Aanderud S; Myking OL; Bassøe HH
Acta Endocrinol (Copenh); 1982 Aug; 100(4):588-94. PubMed ID: 6289586
[TBL] [Abstract][Full Text] [Related]
39. Relative potency in acute and chronic suppressive effects of prednisolone and betamethasone on the hypothalamic-pituitary-adrenal axis in man.
Morimoto Y; Oishi T; Hanasaki N; Miyatake A; Noma K; Yamamura Y
Endocrinol Jpn; 1980 Oct; 27(5):659-66. PubMed ID: 6263598
[TBL] [Abstract][Full Text] [Related]
40. Circadian rhythm of adrenergic regulation of adrenocorticotropin and cortisol secretion in man.
Naylor MR; Krishnan KR; Manepalli AN; Ritchie JC; Wilson WH; Carroll BJ
J Clin Endocrinol Metab; 1988 Aug; 67(2):404-6. PubMed ID: 2839538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
